Dr. Ravi Kapur is a co-founder and Chief Executive Officer of AutoIVF and serves on the company’s Board of Directors, guiding corporate strategy, capital formation, and operational execution.

Dr. Kapur is a technology entrepreneur whose work bridges clinical medicine, microfluidics, and translational science. Prior to founding AutoIVF, he built experience across academic research, clinical environments, and healthcare innovation, developing a disciplined approach to product development that integrates scientific rigor with regulatory strategy, clinical validation, and commercialization planning. His focus is on converting high-impact laboratory innovations into scalable, reliable clinical platforms.

Under Dr. Kapur’s leadership, AutoIVF is being built as a product-driven, evidence-first company, with clear pathways for regulatory approval, manufacturing scalability, and market adoption. He emphasizes structured execution, milestone-driven development, and close partnerships with clinical stakeholders to ensure technologies translate into durable revenue models and defensible market positions.

Dr. Kapur earned a PhD and MSc in Bioengineering (Biomaterials & Regenerative Medicine) from Clemson University and is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE).